AUM: AMFI's average assets under management for July - September 2026, in ₹ crore, for the whole fund (Direct and Regular, Growth and IDCW added up). The same source and period for every fund, so the figures compare.
From AMFI's scheme details and member pages. A dash means AMFI has not published it or it is not loaded, not a zero. AMFI lists fund managers per fund house, not per fund, and reports active SIPs only for the whole industry. The riskometer comes from AMFI's fund performance table, which does not answer automated readers, so it is blank until another source is agreed.
Holdings overlap i
Aditya Birla Sun Life Pharma and Healthcare Fund
Aditya Birla Sun Life Special Opportunities Fund
Aditya Birla Sun Life Pharma and Healthcare Fund
Direct · filing Oct 2026
—
5%
Aditya Birla Sun Life Special Opportunities Fund
Direct · filing Oct 2026
5%
—
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Aditya Birla Sun Life Pharma and Healthcare Fund and Aditya Birla Sun Life Special Opportunities Fund
Overlap
4.9%
smaller weight of each shared stock, added up
Stocks in common
5
of 40 and 68
Weight in common
10% · 5%
of each fund's money
Filings compared
Oct 2026 · Oct 2026
same month
Common stock
Aditya Birla Sun Life Pharma and Healthcare Fund
Aditya Birla Sun Life Special Opportunities Fund
Counts toward overlap
Biocon Limited
1.79%
1.09%
1.09%
Ajanta Pharma Limited
4.17%
1.05%
1.05%
Anthem Biosciences Limited
1.08%
1.04%
1.04%
Onesource Specialty Pharma Limited
0.86%
1.00%
0.86%
Fortis Healthcare Limited
2.39%
0.81%
0.81%
5 stocks
10.3%
5.0%
4.9%
Only in Aditya Birla Sun Life Pharma and Healthcare Fund (35)
Torrent Pharmaceuticals Limited
8.83%
Sun Pharmaceutical Industries Limited
8.35%
Cipla Limited
7.10%
Apollo Hospitals Enterprise Limited
6.60%
Sai Life Sciences Limited
4.54%
Aurobindo Pharma Limited
4.50%
Dr. Lal Path Labs Limited
3.90%
Mankind Pharma Limited
3.56%
Emcure Pharmaceuticals Limited
3.06%
Abbott India Limited
3.05%
Lupin Limited
2.89%
Gland Pharma Limited
2.86%
IPCA Laboratories Limited
2.69%
Divi's Laboratories Limited
2.34%
Corona Remedies Ltd.
2.31%
Dr. Reddy's Laboratories Limited
1.85%
Procter & Gamble Health Limited
1.83%
Alkem Laboratories Limited
1.65%
Eris Lifesciences Limited
1.59%
Jupiter Life Line Hospitals Limited
1.55%
Metropolis Healthcare Limited
1.54%
Piramal Pharma Limited
1.53%
Thyrocare Technologies Limited
1.49%
Vijaya Diagnostic Centre Limited
1.04%
Manipal Health Enterprises Limited
1.00%
and 10 smaller holdings (7.5% of the fund).
Only in Aditya Birla Sun Life Special Opportunities Fund (63)
Aditya Infotech Limited
6.90%
Bharti Airtel Limited
4.14%
Union Bank of India
3.68%
ICICI Bank Limited
3.09%
Meesho Limited
2.98%
Billionbrains Garage Ventures Limited
2.47%
Shriram Finance Limited
2.47%
Spr Auto Technologies Limited
2.41%
Axis Bank Limited
2.11%
Bank Of Maharashtra
2.06%
Infosys Limited
1.92%
Navin Fluorine International Limited
1.90%
Ambuja Cements Limited
1.88%
Wheels India Limited
1.86%
SS Retail Ltd.
1.81%
Sedemac Mechatronics Ltd.
1.80%
Carborundum Universal Limited
1.79%
Coforge Limited
1.66%
Persistent Systems Limited
1.63%
Ujjivan Small Finance Bank Limited
1.58%
Vedanta Aluminium Metal Limited
1.56%
Indus Towers Limited
1.53%
Varun Beverages Limited
1.51%
RBL Bank Limited
1.51%
Tata Motors Ltd
1.50%
and 38 smaller holdings (34.3% of the fund).
Method: from each fund's latest monthly portfolio filing, shares only (Indian and foreign equity; bonds, cash and derivatives are left out). Overlap adds up, for every stock both hold, the smaller of the two weights.